Jundishapur Journal of Microbiology

Published by: Kowsar

The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey

Derya Keten 1 , Mehmet Emin Ova 2 , Hamit Sirri Keten 3 , * , Alper Keten 4 , Evrim Gulderen 1 , Seray Tumer 5 , Ahmet Caliskan 5 and Suleyman Kulotu 1
Authors Information
1 Department of Clinical Microbiology and Infectious Diseases, Necip Fazil City Hospital, Kahramanmaras, Turkey
2 Kahramanmaras Closed Prison, General Practice, Kahramanmaras, Turkey
3 Department of Family Medicine, Kurtul Family Health Center, Kahramanmaras, Turkey
4 Council of Forensic Medicine, Kahramanmaras Branch, Kahramanmaras, Turkey
5 Department of Microbiology, Necip Fazil City Hospital, Kahramanmaras, Turkey
Article information
  • Jundishapur Journal of Microbiology: February 01, 2016, 9 (2); e31598
  • Published Online: February 13, 2016
  • Article Type: Research Article
  • Received: July 16, 2015
  • Revised: December 8, 2015
  • Accepted: December 16, 2015
  • DOI: 10.5812/jjm.31598

To Cite: Keten D, Emin Ova M, Sirri Keten H, Keten A, Gulderen E, et al. The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey, Jundishapur J Microbiol. 2016 ; 9(2):e31598. doi: 10.5812/jjm.31598.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Dienstag JL, Delemos AS. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015; : 1439-68
  • 2. Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, et al. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010. Med J Aust. 2014; 200(5): 277-80[PubMed]
  • 3. Tumer A. What is AIDS? 2013;
  • 4. Alvarez KJ, Befus M, Herzig CT, Larson E. Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities. J Infect Public Health. 2014; 7(6): 517-21[DOI][PubMed]
  • 5. Lemberg BD, Shaw-Stiffel TA. Hepatic disease in injection drug users. Infect Dis Clin North Am. 2002; 16(3): 667-79[PubMed]
  • 6. Murrill CS, Weeks H, Castrucci BC, Weinstock HS, Bell BP, Spruill C, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002; 92(3): 385-7[PubMed]
  • 7. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791): 571-83[DOI][PubMed]
  • 8. Vescio MF, Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health. 2008; 62(4): 305-13[DOI][PubMed]
  • 9. Kinner SA, Jenkinson R, Gouillou M, Milloy MJ. High-risk drug-use practices among a large sample of Australian prisoners. Drug Alcohol Depend. 2012; 126(1-2): 156-60[DOI][PubMed]
  • 10. Pollini RA, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriquez C, et al. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend. 2009; 103(1-2): 52-8[DOI][PubMed]
  • 11. Bretana NA, Boelen L, Bull R, Teutsch S, White PA, Lloyd AR, et al. Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012. Emerg Infect Dis. 2015; 21(5): 765-74[DOI][PubMed]
  • 12. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011; 377(9769): 956-65[DOI][PubMed]
  • 13. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013; 58(4): 1215-24[DOI][PubMed]
  • 14. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H. Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users. Hepat Mon. 2011; 11(1): 19-22[PubMed]
  • 15. Nokhodian Z, Yaran M, Adibi P, Kassaian N, Meshkati M, Ataei B. Seroprevalence of hepatitis B markers among incarcerated intravenous drug users. J Res Med Sci. 2014; 19-6[PubMed]
  • 16. Shirani K, Nokhodian Z, Kassaian N, Adibi P, Naeini AE, Ataei B. The prevalence of isolated hepatitis B core antibody and its related risk factors among male injected drug users in Isfahan prisons. Adv Biomed Res. 2015; 4: 17[DOI][PubMed]
  • 17. Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, et al. Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan. Drug Alcohol Depend. 2015; 151: 68-75[DOI][PubMed]
  • 18. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 19. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008; 48(1): 148-62[DOI][PubMed]
  • 20. Tozun N, Ozdogan OC, Cakaloglu Y, Idilman R, Karasu Z, Akarca US, et al. A nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology. 2010; 52: 697
  • 21. Mıstık, R. . viral Hepatitis 2013. 2013;
  • 22. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015; 61(1): 77-87[DOI][PubMed]
  • 23. Sanlidag T, Akcali S, Ozbakkaloglu B, Ertekin D, Akduman E. [Distribution of hepatitis C virus genotypes in Manisa region, Turkey]. Mikrobiyol Bul. 2009; 43(4): 613-8[PubMed]
  • 24. Aktas E, Ogedey ED, Kulah C, Begendik Comert F. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey]. Mikrobiyol Bul. 2010; 44(4): 647-50[PubMed]
  • 25. Tezcan S, Ulger M, Aslan G, Yaras S, Altintas E, Sezgin O, et al. [Determination of hepatitis C virus genotype distribution in Mersin province, Turkey]. Mikrobiyol Bul. 2013; 47(2): 332-8[PubMed]
  • 26. Yildiz E, Oztan A, Sar F, Pinarbasi E, Cetin-Atalay R, Akkiz H, et al. Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey. Virus Genes. 2002; 25(2): 169-77[PubMed]
  • 27. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, et al. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat. 1995; 2(6): 297-301[PubMed]
  • 28. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, et al. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol. 2008; 14(8): 1237-43[PubMed]
  • 29. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol. 2000; 60(2): 122-5[PubMed]
  • 30. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat. 2005; 12(4): 405-13[DOI][PubMed]
  • 31. Bourliere M, Halfon P, Portal I. [Treatment of chronic hepatitis C in special groups]. Gastroenterol Clin Biol. 2002; 26 Spec No 2-47[PubMed]
  • 32. de Vries MJ, te Rijdt B, van Nieuwkerk CM. Genotype distribution amongst hepatitis C patients in The Netherlands. Neth J Med. 2006; 64(4): 109-13[PubMed]
  • 33. Mohammad Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol. 2005; 11(26): 4085-9[PubMed]
  • 34. Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, et al. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission. Eur J Epidemiol. 1999; 15(5): 439-45[PubMed]
  • 35. Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect. 2000; 40(2): 176-83[PubMed]
  • 36. Okie S. Sex, drugs, prisons, and HIV. N Engl J Med. 2007; 356(2): 105-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments